Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates.
Sign Up to like & getrecommendations! Published in 2022 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.2c00126
Abstract: Anticancer drug delivery by small molecules offers a number of advantages over conventional macromolecular drug delivery systems. We previously developed phenylcyclopropylamine (PCPA)-drug conjugates (PDCs) as small-molecule-based drug delivery vehicles for targeting lysine-specific demethylase 1 (LSD1)-overexpressing… read more here.
Keywords: vorinostat conjugates; vorinostat; cancer cell; drug ... See more keywords